Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a -28.201\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a.) CC(C)(C)c1ccc(N2C(=N)SCC2=O)cc1
b.) Br.CCCCn1c(=N)n(CC(=O)C(C)(C)C)c2ccccc21
c.) CC(C)c1c(O)c2c(n(-c3ccccc3)c1=O)CCCC2
d.) O=C(CN(C(=O)c1csnn1)c1cccc2ccccc12)NCc1ccccc1
Answer: b. Br.CCCCn1c(=N)n(CC(=O)C(C)(C)C)c2ccccc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Br.CCCCn1c(=N)n(CC(=O)C(C)(C)C)c2ccccc21
Br.CCCCn1c(=N)n(CC(=O)C(C)(C)C)c2ccccc21
1-(3-butyl-2-iminobenzimidazol-1-yl)-3,3-dimethylbutan-2-one;hydrobromide